| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Milk Hypersensitivity | 11 | 2024 | 83 | 4.270 |
Why?
|
| Short Bowel Syndrome | 37 | 2007 | 352 | 3.580 |
Why?
|
| Infant Formula | 14 | 2024 | 194 | 3.350 |
Why?
|
| Probiotics | 22 | 2021 | 387 | 3.330 |
Why?
|
| Intestine, Small | 39 | 2004 | 1217 | 2.080 |
Why?
|
| Milk Proteins | 6 | 2024 | 161 | 1.610 |
Why?
|
| Lactobacillus | 11 | 2010 | 212 | 1.490 |
Why?
|
| Prebiotics | 4 | 2021 | 41 | 1.170 |
Why?
|
| Intestinal Mucosa | 44 | 2001 | 3044 | 1.120 |
Why?
|
| Intestines | 23 | 2020 | 1909 | 1.060 |
Why?
|
| Adaptation, Physiological | 24 | 2004 | 1312 | 1.020 |
Why?
|
| Glucans | 4 | 2015 | 71 | 1.000 |
Why?
|
| Infant Nutritional Physiological Phenomena | 5 | 2020 | 352 | 0.960 |
Why?
|
| Amino Acids | 7 | 2020 | 1716 | 0.950 |
Why?
|
| Ileum | 25 | 2002 | 558 | 0.860 |
Why?
|
| Intestinal Diseases | 10 | 2008 | 505 | 0.760 |
Why?
|
| Diarrhea | 13 | 2012 | 1320 | 0.750 |
Why?
|
| Infant Food | 9 | 2001 | 139 | 0.740 |
Why?
|
| Feces | 6 | 2020 | 1511 | 0.740 |
Why?
|
| Food, Formulated | 11 | 2016 | 103 | 0.730 |
Why?
|
| Enteral Nutrition | 17 | 2003 | 802 | 0.720 |
Why?
|
| Jejunum | 24 | 2001 | 475 | 0.690 |
Why?
|
| Parenteral Nutrition | 19 | 2007 | 663 | 0.690 |
Why?
|
| Gastrointestinal Diseases | 7 | 2010 | 1206 | 0.670 |
Why?
|
| Intestinal Absorption | 19 | 2004 | 400 | 0.670 |
Why?
|
| Milk, Human | 4 | 2020 | 490 | 0.600 |
Why?
|
| Diarrhea, Infantile | 8 | 2003 | 100 | 0.580 |
Why?
|
| Infant | 67 | 2024 | 36535 | 0.560 |
Why?
|
| Protein Hydrolysates | 3 | 2009 | 7 | 0.540 |
Why?
|
| Infant, Newborn | 40 | 2024 | 26422 | 0.540 |
Why?
|
| Nutritional Requirements | 5 | 2015 | 279 | 0.540 |
Why?
|
| Breast Feeding | 5 | 2020 | 1363 | 0.530 |
Why?
|
| Arachidonic Acid | 4 | 2008 | 429 | 0.520 |
Why?
|
| Fermentation | 2 | 2015 | 143 | 0.510 |
Why?
|
| Food Hypersensitivity | 5 | 2008 | 734 | 0.500 |
Why?
|
| Trisaccharides | 1 | 2015 | 50 | 0.500 |
Why?
|
| Intestinal Polyposis | 1 | 2015 | 42 | 0.480 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2015 | 93 | 0.480 |
Why?
|
| Iron, Dietary | 1 | 2015 | 148 | 0.470 |
Why?
|
| Oligosaccharides | 4 | 2012 | 407 | 0.470 |
Why?
|
| Colonic Diseases | 2 | 2015 | 204 | 0.440 |
Why?
|
| Gastrointestinal Tract | 4 | 2023 | 840 | 0.430 |
Why?
|
| Growth Hormone | 5 | 2004 | 573 | 0.430 |
Why?
|
| Parenteral Nutrition, Total | 9 | 2004 | 304 | 0.430 |
Why?
|
| Bifidobacterium | 2 | 2012 | 99 | 0.420 |
Why?
|
| Liver Transplantation | 14 | 2002 | 2401 | 0.400 |
Why?
|
| Cattle | 4 | 2023 | 3819 | 0.400 |
Why?
|
| Malabsorption Syndromes | 8 | 1992 | 135 | 0.390 |
Why?
|
| Rats, Inbred Strains | 25 | 1992 | 2087 | 0.390 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2015 | 372 | 0.370 |
Why?
|
| Immune Tolerance | 2 | 2019 | 2323 | 0.370 |
Why?
|
| Zinc | 10 | 1987 | 677 | 0.360 |
Why?
|
| Twins, Monozygotic | 1 | 2012 | 472 | 0.360 |
Why?
|
| Child, Preschool | 50 | 2021 | 42669 | 0.360 |
Why?
|
| Colitis, Collagenous | 1 | 2010 | 25 | 0.350 |
Why?
|
| Food, Organic | 2 | 2008 | 34 | 0.350 |
Why?
|
| Colonic Polyps | 1 | 2015 | 557 | 0.340 |
Why?
|
| Growth | 2 | 2008 | 366 | 0.330 |
Why?
|
| Budesonide | 1 | 2010 | 162 | 0.320 |
Why?
|
| Dietary Proteins | 4 | 2020 | 960 | 0.320 |
Why?
|
| Rats | 50 | 2002 | 23760 | 0.310 |
Why?
|
| Immunoglobulin A | 1 | 2012 | 992 | 0.300 |
Why?
|
| Glutamine | 3 | 1997 | 577 | 0.300 |
Why?
|
| Child Nutritional Physiological Phenomena | 4 | 2004 | 294 | 0.290 |
Why?
|
| Food Microbiology | 1 | 2008 | 74 | 0.290 |
Why?
|
| Nutritional Physiological Phenomena | 3 | 2000 | 360 | 0.290 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2000 | 542 | 0.270 |
Why?
|
| Microvilli | 7 | 2002 | 235 | 0.270 |
Why?
|
| Child Development | 2 | 2016 | 2330 | 0.270 |
Why?
|
| Gastroesophageal Reflux | 8 | 2007 | 836 | 0.260 |
Why?
|
| Liver Diseases | 11 | 2007 | 1305 | 0.260 |
Why?
|
| Duodenum | 9 | 2003 | 495 | 0.260 |
Why?
|
| Dietary Fats | 6 | 2001 | 2003 | 0.260 |
Why?
|
| Constipation | 3 | 2012 | 570 | 0.260 |
Why?
|
| Colon | 5 | 2012 | 1801 | 0.260 |
Why?
|
| Child | 60 | 2019 | 80917 | 0.250 |
Why?
|
| Digestive System | 4 | 2002 | 244 | 0.250 |
Why?
|
| Hypersensitivity | 3 | 2010 | 1172 | 0.250 |
Why?
|
| Docosahexaenoic Acids | 3 | 2008 | 914 | 0.240 |
Why?
|
| Colitis | 2 | 2012 | 1242 | 0.240 |
Why?
|
| Humans | 145 | 2024 | 768166 | 0.240 |
Why?
|
| Eosinophilic Esophagitis | 2 | 2018 | 205 | 0.240 |
Why?
|
| Immunoglobulin E | 2 | 2023 | 1506 | 0.240 |
Why?
|
| Disaccharidases | 5 | 1998 | 19 | 0.230 |
Why?
|
| Dietary Carbohydrates | 2 | 2020 | 896 | 0.230 |
Why?
|
| Erythromycin | 2 | 1995 | 115 | 0.230 |
Why?
|
| Colic | 1 | 2024 | 43 | 0.230 |
Why?
|
| Gastroenteritis | 2 | 2003 | 235 | 0.220 |
Why?
|
| Sucrase | 9 | 1998 | 51 | 0.220 |
Why?
|
| Insulin-Like Growth Factor I | 8 | 1998 | 1942 | 0.220 |
Why?
|
| Caseins | 2 | 2019 | 105 | 0.210 |
Why?
|
| Transplantation, Homologous | 4 | 2002 | 4833 | 0.210 |
Why?
|
| Male | 104 | 2024 | 364719 | 0.210 |
Why?
|
| Acetates | 2 | 2003 | 317 | 0.210 |
Why?
|
| Periodicity | 2 | 1995 | 348 | 0.210 |
Why?
|
| Dietary Fiber | 5 | 2005 | 767 | 0.210 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2004 | 161 | 0.200 |
Why?
|
| Leukotriene Antagonists | 1 | 2003 | 124 | 0.200 |
Why?
|
| Bacteria | 5 | 2020 | 2216 | 0.200 |
Why?
|
| Amine Oxidase (Copper-Containing) | 2 | 1994 | 41 | 0.200 |
Why?
|
| Vomiting | 4 | 2001 | 655 | 0.200 |
Why?
|
| Animals | 66 | 2023 | 169246 | 0.190 |
Why?
|
| Liver | 19 | 2004 | 7577 | 0.190 |
Why?
|
| Dehydration | 1 | 2003 | 216 | 0.190 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 1994 | 223 | 0.190 |
Why?
|
| Double-Blind Method | 14 | 2020 | 12465 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2002 | 8128 | 0.180 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 6 | 1998 | 208 | 0.180 |
Why?
|
| Glucocorticoids | 1 | 2010 | 2167 | 0.180 |
Why?
|
| Hydrolysis | 2 | 2016 | 646 | 0.180 |
Why?
|
| Infant, Premature | 2 | 2000 | 2124 | 0.170 |
Why?
|
| Fatty Acids, Volatile | 1 | 2020 | 100 | 0.170 |
Why?
|
| Child Nutrition Sciences | 2 | 2018 | 22 | 0.170 |
Why?
|
| Allergens | 4 | 2019 | 1443 | 0.170 |
Why?
|
| Eicosanoids | 1 | 2001 | 284 | 0.170 |
Why?
|
| Female | 60 | 2024 | 397192 | 0.160 |
Why?
|
| Gastroenterology | 4 | 2018 | 593 | 0.160 |
Why?
|
| Biliary Atresia | 3 | 1991 | 88 | 0.160 |
Why?
|
| Fish Oils | 2 | 1994 | 483 | 0.160 |
Why?
|
| Fecal Impaction | 1 | 2018 | 32 | 0.160 |
Why?
|
| Fluid Therapy | 3 | 2003 | 587 | 0.160 |
Why?
|
| Eosinophilia | 1 | 2003 | 556 | 0.150 |
Why?
|
| Prostaglandins E, Synthetic | 2 | 1988 | 14 | 0.150 |
Why?
|
| Inflammation | 4 | 2015 | 10873 | 0.150 |
Why?
|
| Spain | 1 | 2019 | 485 | 0.150 |
Why?
|
| Symbiosis | 1 | 2020 | 297 | 0.140 |
Why?
|
| Nutritional Support | 1 | 1999 | 178 | 0.140 |
Why?
|
| Proctocolitis | 1 | 1997 | 31 | 0.140 |
Why?
|
| Bacteremia | 1 | 2004 | 986 | 0.140 |
Why?
|
| Food Additives | 2 | 2015 | 23 | 0.140 |
Why?
|
| Quinolines | 1 | 2003 | 772 | 0.140 |
Why?
|
| Digestion | 2 | 2015 | 53 | 0.140 |
Why?
|
| Drinking | 1 | 1998 | 196 | 0.140 |
Why?
|
| Octreotide | 1 | 1998 | 156 | 0.140 |
Why?
|
| Gastrointestinal Agents | 1 | 2002 | 511 | 0.140 |
Why?
|
| Carbonated Beverages | 1 | 1998 | 210 | 0.140 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 1997 | 49 | 0.140 |
Why?
|
| Methotrexate | 4 | 1998 | 1721 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 8 | 2009 | 7477 | 0.130 |
Why?
|
| Enterocolitis | 1 | 1997 | 106 | 0.130 |
Why?
|
| Tacrolimus | 2 | 2002 | 750 | 0.130 |
Why?
|
| Immunosuppressive Agents | 3 | 2002 | 4206 | 0.130 |
Why?
|
| Graft Rejection | 6 | 2002 | 4492 | 0.130 |
Why?
|
| Crohn Disease | 5 | 2005 | 2295 | 0.130 |
Why?
|
| Immune System | 1 | 2021 | 799 | 0.130 |
Why?
|
| Cholestasis, Intrahepatic | 2 | 2004 | 75 | 0.120 |
Why?
|
| DNA | 16 | 2001 | 7214 | 0.120 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2000 | 2442 | 0.120 |
Why?
|
| Single-Blind Method | 2 | 2017 | 1587 | 0.120 |
Why?
|
| Hepatocytes | 1 | 2002 | 1247 | 0.120 |
Why?
|
| Hydrogen | 1 | 2015 | 171 | 0.120 |
Why?
|
| Hyperplasia | 6 | 2001 | 1151 | 0.120 |
Why?
|
| Weight Gain | 4 | 2001 | 2359 | 0.110 |
Why?
|
| Immunity | 2 | 2009 | 1003 | 0.110 |
Why?
|
| RNA, Messenger | 4 | 2018 | 12800 | 0.110 |
Why?
|
| Breath Tests | 1 | 2015 | 300 | 0.110 |
Why?
|
| Blood Proteins | 5 | 1986 | 1191 | 0.110 |
Why?
|
| Societies, Medical | 4 | 2018 | 3968 | 0.110 |
Why?
|
| Insulin-Like Growth Factor II | 5 | 1996 | 271 | 0.110 |
Why?
|
| Research | 1 | 2002 | 1979 | 0.110 |
Why?
|
| Th2 Cells | 1 | 2018 | 1078 | 0.110 |
Why?
|
| Postoperative Period | 7 | 1998 | 1826 | 0.100 |
Why?
|
| Colchicine | 2 | 1984 | 257 | 0.100 |
Why?
|
| Esophagus | 1 | 2018 | 1042 | 0.100 |
Why?
|
| Sigmoidoscopy | 3 | 1997 | 150 | 0.100 |
Why?
|
| Methylglucosides | 1 | 1991 | 35 | 0.100 |
Why?
|
| Adolescent | 29 | 2018 | 89169 | 0.100 |
Why?
|
| Organ Size | 9 | 1996 | 2267 | 0.100 |
Why?
|
| Proteins | 11 | 1998 | 6009 | 0.100 |
Why?
|
| Interprofessional Relations | 1 | 2018 | 997 | 0.100 |
Why?
|
| Prospective Studies | 8 | 2024 | 54926 | 0.100 |
Why?
|
| Transplantation Conditioning | 1 | 1998 | 1601 | 0.090 |
Why?
|
| Fatty Acids, Essential | 2 | 1990 | 97 | 0.090 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 2 | 2002 | 26 | 0.090 |
Why?
|
| Nebraska | 4 | 2002 | 33 | 0.090 |
Why?
|
| Dietary Supplements | 3 | 2015 | 3445 | 0.090 |
Why?
|
| Antacids | 1 | 1991 | 94 | 0.090 |
Why?
|
| Galactose | 1 | 2012 | 300 | 0.090 |
Why?
|
| Defecation | 1 | 2012 | 191 | 0.090 |
Why?
|
| Aluminum | 1 | 1991 | 150 | 0.090 |
Why?
|
| Safflower Oil | 3 | 1999 | 29 | 0.090 |
Why?
|
| Polysaccharides | 1 | 1997 | 1024 | 0.090 |
Why?
|
| Growth Substances | 2 | 1992 | 759 | 0.080 |
Why?
|
| Autoimmune Diseases | 1 | 2002 | 2257 | 0.080 |
Why?
|
| Lipids | 2 | 1999 | 3343 | 0.080 |
Why?
|
| Follow-Up Studies | 9 | 2019 | 39348 | 0.080 |
Why?
|
| Anthropometry | 4 | 2007 | 1346 | 0.080 |
Why?
|
| Linoleic Acids | 1 | 1989 | 39 | 0.080 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2010 | 491 | 0.080 |
Why?
|
| Acute Disease | 4 | 2012 | 7243 | 0.080 |
Why?
|
| Carrier Proteins | 6 | 2002 | 4937 | 0.080 |
Why?
|
| Biopsy | 8 | 1987 | 6793 | 0.080 |
Why?
|
| Age Factors | 5 | 2015 | 18412 | 0.080 |
Why?
|
| Cross-Over Studies | 1 | 2015 | 2107 | 0.080 |
Why?
|
| Pancreas | 4 | 1995 | 1700 | 0.080 |
Why?
|
| Chronic Disease | 7 | 2002 | 9384 | 0.080 |
Why?
|
| Body Weight | 11 | 2000 | 4627 | 0.080 |
Why?
|
| Prostaglandins F | 1 | 1988 | 80 | 0.080 |
Why?
|
| Microtubules | 2 | 1984 | 1064 | 0.080 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2017 | 1178 | 0.080 |
Why?
|
| Prostaglandins E | 1 | 1988 | 166 | 0.080 |
Why?
|
| Treatment Outcome | 12 | 2008 | 65371 | 0.080 |
Why?
|
| Infant Behavior | 1 | 2009 | 157 | 0.080 |
Why?
|
| Triglycerides | 6 | 1992 | 2464 | 0.080 |
Why?
|
| Thromboxane B2 | 1 | 1988 | 143 | 0.080 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2020 | 1049 | 0.070 |
Why?
|
| Symporters | 2 | 2002 | 363 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 2008 | 0.070 |
Why?
|
| Gastrointestinal Hemorrhage | 3 | 2012 | 1126 | 0.070 |
Why?
|
| Consumer Product Safety | 1 | 2008 | 122 | 0.070 |
Why?
|
| Time Factors | 13 | 2007 | 40218 | 0.070 |
Why?
|
| Hyperbilirubinemia, Hereditary | 1 | 1986 | 2 | 0.070 |
Why?
|
| Crigler-Najjar Syndrome | 1 | 1986 | 2 | 0.070 |
Why?
|
| 16,16-Dimethylprostaglandin E2 | 1 | 1987 | 22 | 0.070 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 1988 | 113 | 0.070 |
Why?
|
| Intestinal Obstruction | 2 | 2003 | 433 | 0.070 |
Why?
|
| Nutrition Therapy | 1 | 2008 | 101 | 0.070 |
Why?
|
| Administration, Oral | 3 | 2004 | 4030 | 0.070 |
Why?
|
| Heartburn | 1 | 2007 | 71 | 0.070 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 1986 | 43 | 0.070 |
Why?
|
| North America | 2 | 2018 | 1289 | 0.070 |
Why?
|
| Dexamethasone | 1 | 1994 | 1965 | 0.070 |
Why?
|
| Recurrence | 8 | 2005 | 8509 | 0.070 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1995 | 1334 | 0.060 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 1987 | 304 | 0.060 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1988 | 292 | 0.060 |
Why?
|
| Hordeum | 1 | 2005 | 18 | 0.060 |
Why?
|
| Retrospective Studies | 15 | 2019 | 81762 | 0.060 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 1986 | 131 | 0.060 |
Why?
|
| alpha-Glucosidases | 3 | 1991 | 46 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 9263 | 0.060 |
Why?
|
| Alkaloids | 1 | 1986 | 192 | 0.060 |
Why?
|
| Muscles | 2 | 1987 | 1582 | 0.060 |
Why?
|
| Podophyllotoxin | 1 | 1984 | 20 | 0.060 |
Why?
|
| Tissue Donors | 5 | 2002 | 2381 | 0.060 |
Why?
|
| Glucagon | 1 | 1986 | 535 | 0.060 |
Why?
|
| Rectum | 2 | 2001 | 900 | 0.060 |
Why?
|
| Hepatectomy | 3 | 1996 | 588 | 0.060 |
Why?
|
| Respiratory Tract Infections | 1 | 2012 | 1014 | 0.060 |
Why?
|
| Cholecystokinin | 2 | 1995 | 115 | 0.060 |
Why?
|
| Injections, Subcutaneous | 3 | 1998 | 687 | 0.060 |
Why?
|
| History, 21st Century | 2 | 2018 | 1573 | 0.060 |
Why?
|
| Adaptation, Biological | 1 | 2004 | 147 | 0.050 |
Why?
|
| Combined Modality Therapy | 4 | 2004 | 8542 | 0.050 |
Why?
|
| Diet Therapy | 1 | 2004 | 150 | 0.050 |
Why?
|
| Government Regulation | 1 | 2008 | 525 | 0.050 |
Why?
|
| Glucose Tolerance Test | 1 | 1986 | 1183 | 0.050 |
Why?
|
| Sickness Impact Profile | 1 | 2004 | 299 | 0.050 |
Why?
|
| Infant Welfare | 1 | 2003 | 79 | 0.050 |
Why?
|
| Electrolytes | 3 | 1998 | 279 | 0.050 |
Why?
|
| Pediatrics | 1 | 2018 | 3629 | 0.050 |
Why?
|
| Glycemic Index | 1 | 2005 | 400 | 0.050 |
Why?
|
| Quality of Life | 1 | 2004 | 13490 | 0.050 |
Why?
|
| Perception | 1 | 2009 | 1209 | 0.050 |
Why?
|
| Bacterial Adhesion | 1 | 2004 | 305 | 0.050 |
Why?
|
| Optic Nerve Diseases | 1 | 1986 | 342 | 0.050 |
Why?
|
| Protein Biosynthesis | 4 | 1998 | 2094 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 6082 | 0.050 |
Why?
|
| Survival Rate | 6 | 2007 | 12840 | 0.050 |
Why?
|
| Insulin | 4 | 2005 | 6607 | 0.050 |
Why?
|
| Vinblastine | 1 | 1984 | 487 | 0.050 |
Why?
|
| Liver Regeneration | 1 | 2004 | 214 | 0.050 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2004 | 219 | 0.050 |
Why?
|
| Polyps | 1 | 2004 | 200 | 0.050 |
Why?
|
| Minerals | 1 | 1983 | 282 | 0.050 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2007 | 583 | 0.050 |
Why?
|
| RNA, Bacterial | 1 | 2004 | 393 | 0.050 |
Why?
|
| Sulfides | 1 | 2003 | 171 | 0.050 |
Why?
|
| History, 20th Century | 2 | 2018 | 2766 | 0.050 |
Why?
|
| Abnormalities, Multiple | 2 | 1987 | 1424 | 0.050 |
Why?
|
| Etodolac | 1 | 2001 | 19 | 0.050 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1986 | 622 | 0.050 |
Why?
|
| Random Allocation | 3 | 1997 | 2396 | 0.050 |
Why?
|
| Astrocytoma | 1 | 1986 | 774 | 0.050 |
Why?
|
| Glycine | 2 | 1997 | 672 | 0.050 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2001 | 93 | 0.050 |
Why?
|
| Cyclopropanes | 1 | 2003 | 436 | 0.050 |
Why?
|
| Glucose | 6 | 1995 | 4352 | 0.050 |
Why?
|
| Tetracycline | 1 | 1982 | 216 | 0.050 |
Why?
|
| Saccharomyces | 1 | 2001 | 62 | 0.050 |
Why?
|
| Peptides | 1 | 1993 | 4354 | 0.050 |
Why?
|
| Enteritis | 1 | 2002 | 164 | 0.050 |
Why?
|
| Bacterial Translocation | 1 | 2000 | 74 | 0.040 |
Why?
|
| Vitamins | 2 | 1992 | 1638 | 0.040 |
Why?
|
| Algorithms | 2 | 2018 | 14164 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1987 | 1656 | 0.040 |
Why?
|
| Adult | 23 | 2007 | 223646 | 0.040 |
Why?
|
| Lactose | 1 | 2000 | 95 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2002 | 398 | 0.040 |
Why?
|
| Gastrointestinal Motility | 1 | 2001 | 235 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 1986 | 1276 | 0.040 |
Why?
|
| Phospholipids | 2 | 2000 | 787 | 0.040 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2001 | 361 | 0.040 |
Why?
|
| DNA Primers | 1 | 2004 | 2828 | 0.040 |
Why?
|
| Actuarial Analysis | 2 | 1996 | 370 | 0.040 |
Why?
|
| Hair | 1 | 1983 | 508 | 0.040 |
Why?
|
| Serum Albumin | 4 | 2000 | 677 | 0.040 |
Why?
|
| Ethanol | 2 | 1983 | 1331 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 1983 | 871 | 0.040 |
Why?
|
| Hypertonic Solutions | 1 | 1998 | 82 | 0.040 |
Why?
|
| Rectal Diseases | 2 | 1976 | 142 | 0.040 |
Why?
|
| Brazil | 1 | 2003 | 1250 | 0.040 |
Why?
|
| Eating | 3 | 1997 | 1542 | 0.040 |
Why?
|
| Transplantation, Isogeneic | 1 | 1998 | 249 | 0.040 |
Why?
|
| Monosaccharides | 1 | 1998 | 64 | 0.040 |
Why?
|
| Atrophy | 2 | 1998 | 1646 | 0.040 |
Why?
|
| Clinical Enzyme Tests | 1 | 1998 | 114 | 0.040 |
Why?
|
| Syndrome | 3 | 1995 | 3272 | 0.040 |
Why?
|
| Rural Population | 1 | 1989 | 2325 | 0.040 |
Why?
|
| Nursing Assessment | 1 | 1998 | 107 | 0.040 |
Why?
|
| Organ Preservation | 2 | 1994 | 393 | 0.040 |
Why?
|
| Cholestasis | 1 | 1981 | 385 | 0.040 |
Why?
|
| Severity of Illness Index | 4 | 2007 | 15948 | 0.040 |
Why?
|
| Gastroschisis | 1 | 1998 | 99 | 0.040 |
Why?
|
| Awards and Prizes | 1 | 2002 | 365 | 0.040 |
Why?
|
| Liver Cirrhosis | 2 | 2004 | 1960 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 1998 | 657 | 0.040 |
Why?
|
| Agranulocytosis | 1 | 1977 | 98 | 0.040 |
Why?
|
| Risk Factors | 3 | 2019 | 74944 | 0.040 |
Why?
|
| Therapeutic Irrigation | 1 | 1998 | 297 | 0.030 |
Why?
|
| Postoperative Complications | 8 | 2007 | 15832 | 0.030 |
Why?
|
| Diseases in Twins | 2 | 1991 | 447 | 0.030 |
Why?
|
| Methods | 2 | 1995 | 1066 | 0.030 |
Why?
|
| Dinoprostone | 2 | 1991 | 597 | 0.030 |
Why?
|
| Remission Induction | 2 | 2004 | 2410 | 0.030 |
Why?
|
| Graft Survival | 5 | 2002 | 3887 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2004 | 954 | 0.030 |
Why?
|
| Animals, Newborn | 3 | 1995 | 2678 | 0.030 |
Why?
|
| Muromonab-CD3 | 1 | 1996 | 104 | 0.030 |
Why?
|
| Rats, Inbred Lew | 2 | 1998 | 1162 | 0.030 |
Why?
|
| Consanguinity | 1 | 1998 | 460 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2000 | 528 | 0.030 |
Why?
|
| Esophagogastric Junction | 1 | 1978 | 351 | 0.030 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2004 | 957 | 0.030 |
Why?
|
| Chylous Ascites | 1 | 1996 | 21 | 0.030 |
Why?
|
| Esophageal Diseases | 1 | 1977 | 167 | 0.030 |
Why?
|
| Manometry | 1 | 1978 | 459 | 0.030 |
Why?
|
| United States | 4 | 2024 | 73039 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2001 | 1622 | 0.030 |
Why?
|
| Rotavirus Infections | 1 | 1997 | 85 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 733 | 0.030 |
Why?
|
| Stomach Diseases | 1 | 1997 | 134 | 0.030 |
Why?
|
| Energy Intake | 5 | 2001 | 2146 | 0.030 |
Why?
|
| Cholesterol | 2 | 2002 | 2914 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 2486 | 0.030 |
Why?
|
| DNA, Antisense | 1 | 1995 | 44 | 0.030 |
Why?
|
| Benzodiazepinones | 1 | 1995 | 50 | 0.030 |
Why?
|
| Anemia, Hemolytic | 1 | 1976 | 164 | 0.030 |
Why?
|
| Bone and Bones | 1 | 1986 | 2589 | 0.030 |
Why?
|
| Parents | 1 | 2009 | 3595 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 4 | 1982 | 423 | 0.030 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1976 | 244 | 0.030 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 1995 | 108 | 0.030 |
Why?
|
| Hernia, Hiatal | 1 | 1976 | 91 | 0.030 |
Why?
|
| Hepatic Encephalopathy | 1 | 1976 | 144 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 1001 | 0.030 |
Why?
|
| Regression Analysis | 2 | 1997 | 6340 | 0.030 |
Why?
|
| Somatomedins | 1 | 1995 | 179 | 0.030 |
Why?
|
| Tritium | 2 | 1986 | 707 | 0.030 |
Why?
|
| Antilymphocyte Serum | 1 | 1996 | 492 | 0.030 |
Why?
|
| Bronchiolitis, Viral | 1 | 1995 | 82 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1987 | 2333 | 0.030 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 1998 | 327 | 0.030 |
Why?
|
| Isoniazid | 1 | 1976 | 288 | 0.030 |
Why?
|
| Liver Failure | 1 | 1996 | 252 | 0.030 |
Why?
|
| Microsomes, Liver | 4 | 1982 | 174 | 0.030 |
Why?
|
| Body Height | 1 | 2000 | 1565 | 0.030 |
Why?
|
| Prognosis | 4 | 2004 | 30010 | 0.030 |
Why?
|
| Cyclosporine | 1 | 1996 | 777 | 0.030 |
Why?
|
| Peru | 1 | 1997 | 890 | 0.030 |
Why?
|
| Aminosalicylic Acids | 1 | 1993 | 37 | 0.030 |
Why?
|
| Food | 1 | 2018 | 768 | 0.030 |
Why?
|
| ABO Blood-Group System | 1 | 1996 | 381 | 0.030 |
Why?
|
| Family | 3 | 1996 | 3209 | 0.030 |
Why?
|
| Celiac Disease | 1 | 2001 | 820 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1997 | 646 | 0.030 |
Why?
|
| Gastrointestinal Hormones | 1 | 1994 | 101 | 0.030 |
Why?
|
| Chlorides | 1 | 1976 | 666 | 0.030 |
Why?
|
| Gluconates | 1 | 1993 | 31 | 0.030 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1977 | 549 | 0.030 |
Why?
|
| Colitis, Ulcerative | 2 | 1997 | 1926 | 0.030 |
Why?
|
| Catheterization | 1 | 1978 | 1430 | 0.030 |
Why?
|
| Sulfasalazine | 1 | 1993 | 85 | 0.030 |
Why?
|
| Reoperation | 2 | 2000 | 4329 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 1995 | 436 | 0.030 |
Why?
|
| Secretin | 1 | 1993 | 57 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2018 | 812 | 0.030 |
Why?
|
| Base Sequence | 1 | 2004 | 12421 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2002 | 1886 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 14729 | 0.030 |
Why?
|
| Rabbits | 4 | 1986 | 4772 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2004 | 6316 | 0.030 |
Why?
|
| Glycoproteins | 3 | 1986 | 2202 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2000 | 1812 | 0.030 |
Why?
|
| Disease Management | 1 | 2003 | 2536 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2003 | 10101 | 0.020 |
Why?
|
| Selenium | 1 | 1995 | 418 | 0.020 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 13014 | 0.020 |
Why?
|
| Stromal Cells | 1 | 1998 | 1336 | 0.020 |
Why?
|
| Jejunoileal Bypass | 1 | 1992 | 13 | 0.020 |
Why?
|
| 3-O-Methylglucose | 1 | 1991 | 37 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 1977 | 1528 | 0.020 |
Why?
|
| Forecasting | 1 | 2001 | 2945 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2020 | 8741 | 0.020 |
Why?
|
| Neutropenia | 1 | 1977 | 892 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 10399 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2017 | 2603 | 0.020 |
Why?
|
| Growth Disorders | 1 | 1976 | 635 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2004 | 24315 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 1987 | 4362 | 0.020 |
Why?
|
| Mannitol | 1 | 1991 | 176 | 0.020 |
Why?
|
| Europe | 1 | 2018 | 3436 | 0.020 |
Why?
|
| Aging | 2 | 2000 | 8744 | 0.020 |
Why?
|
| Incidence | 2 | 2018 | 21538 | 0.020 |
Why?
|
| Creatinine | 2 | 2000 | 1918 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2005 | 6430 | 0.020 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 1995 | 365 | 0.020 |
Why?
|
| Leukotriene B4 | 1 | 1991 | 281 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1998 | 1397 | 0.020 |
Why?
|
| Putrescine | 1 | 1989 | 42 | 0.020 |
Why?
|
| Permeability | 1 | 1991 | 725 | 0.020 |
Why?
|
| Spermidine | 1 | 1989 | 63 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 8054 | 0.020 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1976 | 843 | 0.020 |
Why?
|
| Decision Making | 1 | 2003 | 3953 | 0.020 |
Why?
|
| Hepatitis | 1 | 1991 | 227 | 0.020 |
Why?
|
| Milk | 1 | 2012 | 438 | 0.020 |
Why?
|
| Home Nursing | 1 | 1989 | 92 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2021 | 3080 | 0.020 |
Why?
|
| Premedication | 2 | 1982 | 246 | 0.020 |
Why?
|
| Sepsis | 1 | 2003 | 2608 | 0.020 |
Why?
|
| Guanidines | 1 | 1989 | 194 | 0.020 |
Why?
|
| Glycogen Storage Disease Type IV | 1 | 1987 | 7 | 0.020 |
Why?
|
| Cell Division | 4 | 1998 | 4473 | 0.020 |
Why?
|
| Lymphangiectasis, Intestinal | 1 | 1987 | 10 | 0.020 |
Why?
|
| Linoleic Acid | 1 | 1989 | 158 | 0.020 |
Why?
|
| Dinoprost | 1 | 1988 | 139 | 0.020 |
Why?
|
| Duodenoscopy | 1 | 1987 | 45 | 0.020 |
Why?
|
| Glycogen Storage Disease | 1 | 1987 | 41 | 0.020 |
Why?
|
| Phenobarbital | 2 | 1986 | 192 | 0.020 |
Why?
|
| Protein-Losing Enteropathies | 1 | 1987 | 45 | 0.020 |
Why?
|
| Hospitals, University | 2 | 2002 | 570 | 0.020 |
Why?
|
| Parenteral Nutrition Solutions | 2 | 1988 | 30 | 0.020 |
Why?
|
| Lactulose | 1 | 2007 | 32 | 0.020 |
Why?
|
| Sigmoidoscopes | 2 | 1976 | 5 | 0.020 |
Why?
|
| Nitrogen | 1 | 1988 | 345 | 0.020 |
Why?
|
| Vitamin E | 2 | 1992 | 874 | 0.020 |
Why?
|
| Hypertrophy | 1 | 1989 | 562 | 0.020 |
Why?
|
| Iron | 2 | 1987 | 1813 | 0.020 |
Why?
|
| Heparin | 1 | 1994 | 1636 | 0.020 |
Why?
|
| Pregnancy | 3 | 2004 | 30256 | 0.020 |
Why?
|
| Cause of Death | 1 | 1997 | 3721 | 0.020 |
Why?
|
| Solutions | 2 | 1988 | 409 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 1996 | 1546 | 0.020 |
Why?
|
| Cell Movement | 1 | 2018 | 5210 | 0.020 |
Why?
|
| Polyethylene Terephthalates | 1 | 1986 | 112 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2007 | 15454 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1998 | 2541 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 2 | 1979 | 414 | 0.020 |
Why?
|
| Leucyl Aminopeptidase | 1 | 1985 | 12 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 1995 | 1294 | 0.020 |
Why?
|
| Term Birth | 1 | 2007 | 140 | 0.020 |
Why?
|
| Glucuronosyltransferase | 1 | 1986 | 136 | 0.020 |
Why?
|
| Thymidine | 1 | 1986 | 297 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 1991 | 1196 | 0.020 |
Why?
|
| Polytetrafluoroethylene | 1 | 1986 | 245 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 1982 | 4712 | 0.020 |
Why?
|
| Polyglycolic Acid | 1 | 1986 | 408 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2018 | 41754 | 0.010 |
Why?
|
| Bilirubin | 1 | 1986 | 438 | 0.010 |
Why?
|
| Cachexia | 1 | 1986 | 202 | 0.010 |
Why?
|
| Vitamin K | 1 | 1987 | 314 | 0.010 |
Why?
|
| Obesity | 6 | 1983 | 13090 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 1991 | 837 | 0.010 |
Why?
|
| Calcium, Dietary | 1 | 1987 | 533 | 0.010 |
Why?
|
| Trichloroacetic Acid | 1 | 1984 | 48 | 0.010 |
Why?
|
| Pentobarbital | 2 | 1982 | 153 | 0.010 |
Why?
|
| Amylases | 2 | 1995 | 171 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 2 | 1995 | 69 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 11095 | 0.010 |
Why?
|
| Vitamin A | 1 | 1987 | 611 | 0.010 |
Why?
|
| Epithelium | 3 | 1995 | 1607 | 0.010 |
Why?
|
| Carbachol | 2 | 1995 | 223 | 0.010 |
Why?
|
| Phototherapy | 1 | 1986 | 368 | 0.010 |
Why?
|
| Drug Stability | 1 | 1983 | 291 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 1996 | 3049 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1984 | 567 | 0.010 |
Why?
|
| Postprandial Period | 1 | 2005 | 320 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 1987 | 553 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1986 | 1534 | 0.010 |
Why?
|
| Reye Syndrome | 1 | 1982 | 28 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1991 | 4860 | 0.010 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2002 | 28 | 0.010 |
Why?
|
| Torsion Abnormality | 1 | 2003 | 92 | 0.010 |
Why?
|
| Glucosamine | 1 | 1983 | 128 | 0.010 |
Why?
|
| Metronidazole | 1 | 2004 | 236 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 1985 | 863 | 0.010 |
Why?
|
| Guinea Pigs | 2 | 1995 | 1310 | 0.010 |
Why?
|
| Steroid Hydroxylases | 1 | 2002 | 93 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1987 | 1338 | 0.010 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2002 | 64 | 0.010 |
Why?
|
| Fundoplication | 1 | 2003 | 145 | 0.010 |
Why?
|
| Ciprofloxacin | 1 | 2004 | 313 | 0.010 |
Why?
|
| Anastomosis, Surgical | 2 | 1998 | 991 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1983 | 642 | 0.010 |
Why?
|
| Registries | 1 | 2017 | 8375 | 0.010 |
Why?
|
| Endoscopy, Digestive System | 1 | 2004 | 358 | 0.010 |
Why?
|
| Leucine | 1 | 1983 | 547 | 0.010 |
Why?
|
| Albumins | 1 | 1984 | 577 | 0.010 |
Why?
|
| Regeneration | 1 | 1990 | 1524 | 0.010 |
Why?
|
| Placebos | 1 | 2005 | 1667 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2005 | 12252 | 0.010 |
Why?
|
| Hirschsprung Disease | 1 | 1983 | 163 | 0.010 |
Why?
|
| Tubulin | 1 | 1984 | 695 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1990 | 2819 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 1 | 1982 | 265 | 0.010 |
Why?
|
| Middle Aged | 5 | 2005 | 223492 | 0.010 |
Why?
|
| Gastrostomy | 1 | 2003 | 325 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 1986 | 1351 | 0.010 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2000 | 99 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 2000 | 189 | 0.010 |
Why?
|
| Age of Onset | 1 | 2007 | 3347 | 0.010 |
Why?
|
| Abdomen | 2 | 1976 | 1136 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1992 | 5151 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1987 | 1798 | 0.010 |
Why?
|
| Taurocholic Acid | 1 | 1998 | 44 | 0.010 |
Why?
|
| Blood Group Antigens | 1 | 2000 | 183 | 0.010 |
Why?
|
| Necrosis | 1 | 2003 | 1616 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1988 | 2418 | 0.010 |
Why?
|
| Paclitaxel | 1 | 1986 | 1733 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1990 | 10760 | 0.010 |
Why?
|
| Transfection | 2 | 1996 | 5755 | 0.010 |
Why?
|
| Nicotinic Acids | 1 | 1977 | 33 | 0.010 |
Why?
|
| Gallbladder | 1 | 1979 | 308 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 12543 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 2004 | 985 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 1987 | 2337 | 0.010 |
Why?
|
| Hemoglobinuria | 1 | 1976 | 12 | 0.010 |
Why?
|
| Colonic Diseases, Functional | 1 | 1976 | 39 | 0.010 |
Why?
|
| Gestational Age | 1 | 1986 | 3621 | 0.010 |
Why?
|
| Body Fluids | 1 | 1998 | 321 | 0.010 |
Why?
|
| Oligo-1,6-Glucosidase | 1 | 1996 | 7 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1998 | 521 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 1996 | 24 | 0.010 |
Why?
|
| Aspirin | 1 | 1988 | 3135 | 0.010 |
Why?
|
| Devazepide | 1 | 1995 | 4 | 0.010 |
Why?
|
| Models, Animal | 1 | 2002 | 2120 | 0.010 |
Why?
|
| Receptors, Cholecystokinin | 1 | 1995 | 18 | 0.010 |
Why?
|
| Ulcer | 1 | 1977 | 203 | 0.010 |
Why?
|
| Binding Sites | 1 | 1984 | 6020 | 0.010 |
Why?
|
| Cell Line | 3 | 1998 | 15597 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 1998 | 627 | 0.010 |
Why?
|
| Phorbol Esters | 1 | 1995 | 109 | 0.010 |
Why?
|
| Suction | 1 | 1976 | 268 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1986 | 5315 | 0.010 |
Why?
|
| Kidney | 1 | 1991 | 7064 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1981 | 1667 | 0.010 |
Why?
|
| Vena Cava, Inferior | 1 | 1998 | 463 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1976 | 326 | 0.010 |
Why?
|
| Caco-2 Cells | 1 | 1996 | 366 | 0.010 |
Why?
|
| Radiography | 1 | 1986 | 6983 | 0.010 |
Why?
|
| Face | 1 | 1981 | 1029 | 0.010 |
Why?
|
| Morbidity | 1 | 2000 | 1755 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1996 | 6514 | 0.010 |
Why?
|
| Risk | 1 | 1986 | 9613 | 0.010 |
Why?
|
| Myocardium | 1 | 1987 | 4788 | 0.010 |
Why?
|
| Perfusion | 1 | 1979 | 1401 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1979 | 1968 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2004 | 2981 | 0.010 |
Why?
|
| Vitamin D | 1 | 1987 | 3311 | 0.010 |
Why?
|
| Acetic Acid | 1 | 1993 | 59 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1992 | 148 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1996 | 1989 | 0.010 |
Why?
|
| Spirometry | 1 | 1995 | 929 | 0.010 |
Why?
|
| Laparotomy | 1 | 1974 | 458 | 0.010 |
Why?
|
| Colectomy | 1 | 1997 | 696 | 0.010 |
Why?
|
| Hyperbilirubinemia | 1 | 1992 | 74 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 826 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1995 | 1228 | 0.010 |
Why?
|
| Riboflavin | 1 | 1992 | 107 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1998 | 4580 | 0.010 |
Why?
|
| Homeostasis | 1 | 2002 | 3348 | 0.010 |
Why?
|
| Receptors, Somatomedin | 1 | 1990 | 57 | 0.010 |
Why?
|
| Pain | 2 | 1976 | 5100 | 0.010 |
Why?
|
| Point Mutation | 1 | 1995 | 1596 | 0.010 |
Why?
|
| Calcium | 1 | 1983 | 5792 | 0.010 |
Why?
|
| Nucleic Acids | 1 | 1993 | 189 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1998 | 1628 | 0.010 |
Why?
|
| Prevalence | 1 | 2007 | 15869 | 0.010 |
Why?
|
| Disease Progression | 1 | 2007 | 13671 | 0.010 |
Why?
|
| Safety | 1 | 1994 | 1159 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 22291 | 0.000 |
Why?
|
| Binding, Competitive | 1 | 1990 | 1142 | 0.000 |
Why?
|
| Vitamin B 12 | 1 | 1992 | 529 | 0.000 |
Why?
|
| Cyclic AMP | 1 | 1993 | 1470 | 0.000 |
Why?
|
| Carotenoids | 1 | 1992 | 620 | 0.000 |
Why?
|
| Hypnotics and Sedatives | 1 | 1976 | 1191 | 0.000 |
Why?
|
| Blood Coagulation Disorders | 1 | 1991 | 350 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1990 | 2173 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 1730 | 0.000 |
Why?
|
| Catheterization, Peripheral | 1 | 1991 | 347 | 0.000 |
Why?
|
| Disease Models, Animal | 2 | 1992 | 18349 | 0.000 |
Why?
|
| Lung Diseases | 1 | 1995 | 1944 | 0.000 |
Why?
|
| RNA | 1 | 1995 | 2720 | 0.000 |
Why?
|
| DNA Replication | 1 | 1992 | 1427 | 0.000 |
Why?
|
| Kinetics | 1 | 1992 | 6329 | 0.000 |
Why?
|
| Cardiomegaly | 1 | 1987 | 591 | 0.000 |
Why?
|
| Aged | 2 | 1995 | 171504 | 0.000 |
Why?
|
| Postoperative Care | 1 | 1991 | 1480 | 0.000 |
Why?
|
| Transforming Growth Factor beta | 1 | 1992 | 1996 | 0.000 |
Why?
|
| Tyrosine | 1 | 1988 | 1427 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1992 | 6229 | 0.000 |
Why?
|
| Cysteine | 1 | 1988 | 897 | 0.000 |
Why?
|
| Epithelial Cells | 1 | 1995 | 3703 | 0.000 |
Why?
|
| Abdominal Muscles | 1 | 1984 | 172 | 0.000 |
Why?
|
| Genotype | 1 | 1995 | 13045 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 13421 | 0.000 |
Why?
|
| Diet | 1 | 1998 | 8089 | 0.000 |
Why?
|
| Intracranial Pressure | 1 | 1982 | 323 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 17622 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1995 | 19015 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1996 | 11669 | 0.000 |
Why?
|
| Aniline Hydroxylase | 1 | 1977 | 1 | 0.000 |
Why?
|
| Lung | 1 | 1995 | 10099 | 0.000 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1977 | 209 | 0.000 |
Why?
|
| Aniline Compounds | 1 | 1978 | 1094 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1994 | 20760 | 0.000 |
Why?
|
| Hospitalization | 1 | 1988 | 10840 | 0.000 |
Why?
|